DAM
BIIB icon

DLD Asset Management’s Biogen BIIB Stock Holding History

DLD Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-27,500
Closed -$3.85M – 387
2025
Q3 		$3.85M Buy
+27,500
New +$3.72M 0.28% 66
2021
Q3 		– Sell
-20,100
Closed -$6.96M – 133
2021
Q2 		$6.96M Buy
20,100
+2,000
+11% +$606K 0.48% 49
2021
Q1 		$5.07M Sell
18,100
-34,100
-65% -$9.2M 0.14% 61
2020
Q4 		$12.8M Buy
+52,200
New +$13.5M 0.36% 33
2019
Q4 		– Sell
-303,400
Closed -$70.7M – 93
2019
Q3 		$70.7M Buy
+303,400
New +$70.6M 3.58% 9

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

DLD Asset Management's BIIB Position: Q2 2019 in Review

DLD Asset Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 346,700 shares — an estimated $82M sold.

DLD Asset Management first reported a position in BIIB in Q1 2019 and held it in 1 quarter. The position peaked at $82M in Q1 2019. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

  • DLD Asset Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
  • DLD Asset Management sold 346,700 Biogen shares in Q2 2019, an estimated $82M.
  • DLD Asset Management first reported a position in Biogen in Q1 2019 and held it in 1 quarter.
  • DLD Asset Management's Biogen position peaked at $82M in Q1 2019.
  • 1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on DLD Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.